Your browser doesn't support javascript.
loading
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma.
Vdovin, Alexander; Jelinek, Tomas; Zihala, David; Sevcikova, Tereza; Durech, Michal; Sahinbegovic, Hana; Snaurova, Renata; Radhakrishnan, Dhwani; Turi, Marcello; Chyra, Zuzana; Popkova, Tereza; Venglar, Ondrej; Hrdinka, Matous; Hajek, Roman; Simicek, Michal.
Afiliação
  • Vdovin A; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Syllabova 19, 703 00, Czech Republic.
  • Jelinek T; Department of Hematooncology, University Hospital Ostrava, Ostrava, 17. listopadu 1790/5, 708 00, Czech Republic.
  • Zihala D; Faculty of Science, University of Ostrava, Ostrava, 30. dubna 22, 701 03, Czech Republic.
  • Sevcikova T; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Syllabova 19, 703 00, Czech Republic.
  • Durech M; Department of Hematooncology, University Hospital Ostrava, Ostrava, 17. listopadu 1790/5, 708 00, Czech Republic.
  • Sahinbegovic H; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Syllabova 19, 703 00, Czech Republic.
  • Snaurova R; Department of Hematooncology, University Hospital Ostrava, Ostrava, 17. listopadu 1790/5, 708 00, Czech Republic.
  • Radhakrishnan D; Faculty of Science, University of Ostrava, Ostrava, 30. dubna 22, 701 03, Czech Republic.
  • Turi M; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Syllabova 19, 703 00, Czech Republic.
  • Chyra Z; Department of Hematooncology, University Hospital Ostrava, Ostrava, 17. listopadu 1790/5, 708 00, Czech Republic.
  • Popkova T; Faculty of Science, University of Ostrava, Ostrava, 30. dubna 22, 701 03, Czech Republic.
  • Venglar O; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Syllabova 19, 703 00, Czech Republic.
  • Hrdinka M; Department of Hematooncology, University Hospital Ostrava, Ostrava, 17. listopadu 1790/5, 708 00, Czech Republic.
  • Hajek R; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Syllabova 19, 703 00, Czech Republic.
  • Simicek M; Department of Hematooncology, University Hospital Ostrava, Ostrava, 17. listopadu 1790/5, 708 00, Czech Republic.
Nat Commun ; 13(1): 6820, 2022 11 10.
Article em En | MEDLINE | ID: mdl-36357400
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteassoma / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteassoma / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca